Results 131 to 140 of about 584,073 (346)
Background Globally, breast cancer is the most common cancer among women. Nigeria has the highest age-standardized breast cancer mortality rates in Africa, at 25.5 per 100,000.
Tope Olubodun +12 more
doaj +1 more source
Breast density classification with deep convolutional neural networks
Breast density classification is an essential part of breast cancer screening. Although a lot of prior work considered this problem as a task for learning algorithms, to our knowledge, all of them used small and not clinically realistic data both for ...
Cho, Kyunghyun +8 more
core +1 more source
Liquid biopsy enables minimally invasive, real‐time molecular profiling through analysis of circulating biomarkers in biological fluids. This Perspective highlights the importance of training pathologists through integrative educational programs, such as the European Masters in Molecular Pathology, to ensure effective and equitable implementation of ...
Marius Ilié +13 more
wiley +1 more source
A Reality Check for Overdiagnosis Estimates Associated With Breast Cancer Screening [PDF]
Ruth Etzioni +4 more
openalex +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Efficacy of Ultrasonography in Breast Cancer Screening
A good screening test should be widely available, inexpensive, and have high sensitivity and specificity. Mammography is the only screening modality proven to reduce the mortality of breast cancer.
doaj +1 more source
Lightscanning versus mammography for the detection of breast cancer in screening and clinical practice. A Swedish multicenter study [PDF]
A Alveryd +20 more
openalex +1 more source
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source

